Clinical analysis of robotic mitral valve Replacement
10.3760/cma.j.issn.1001-4497.2011.07.003
- VernacularTitle:机器人微创二尖瓣置换术
- Author:
Changqing GAO
;
Ming YANG
;
Gang WANG
;
Jiali WANG
;
Cangsong XIAO
;
Yang WU
;
Yao WANG
- Publication Type:Journal Article
- Keywords:
Cardiac surgical procedures;
Heart valve prosthesis inplarotation;
Mitral valve;
Minimally invasive;
Robotic
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2011;27(7):390-392
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the safety and efficacy of robotic mitral valvereplacement using da Vinci S system.Methods From August 2008 to April 2011, over 400 cases of robotic cardiac surgery have been completed in Chinese PLA general hospital, in which 20 patients with isolated mitral valve stenosis underwent robotic mitral replacement, including 7 male and 13 female patients with a mean age of (44.7 ±9.8) years (ranging from 32 to 65 years). 16 patients had a NYHA class Ⅰ～Ⅱ heart function and 4 patients were NYHA class Ⅲ. Fifteen patients were concomitant with atiral fibrillation. Surgery approach was achieved through 4 right chest ports with femoral perfusion and Chitwood aortic occlusion. Antegrade cold blood cardioplegia was administered directly via chest for myocardial protection. The transesophageal echocardiography was used intraoperatively to estimate the surgical results. Results All patients had successful valve replacement including mechanical and tissue valve replacement. There was no conversion to a median sternotomy. The mean cardiopulmonary bypass and arrested heart time were(137.1 ±21.9) minutes and (99.3 ±17.4) minutes. Echocardiographic follow-up in all patients revealed no complications. Conclusion Robotic mitral valve replacement is safe and efficacious in the patients with isolated mitral valve disease.
